Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.
NJEDA to Make Additional Lab Space Available for State’s Growing Biotechnology Companies
Trenton, NJ, August 21, 2017 — The New Jersey Economic Development Authority (EDA) on August 17 announced it will again expand its successful incubator program with the creation of the Biotechnology Development Center (BDC) on the 50-acre Technology Centre of New Jersey research park in North Brunswick.
The BDC will offer suites of intermediate lab and office space from 3,400 to 10,000 square feet for emerging life sciences companies including those that have outgrown incubator space and other early stage companies looking to expand. More than 32,600 square feet of new space is now available at the BDC. Continue reading
NJ Economic Development Authority Board Takes Action to Drive Pharmaceutical Manufacturing Growth
Trenton, NJ, August 13, 2017 — The Board of the New Jersey Economic Development Authority (EDA) took action on August 8 that will help advance one of the key legislative objectives of the Economic Opportunity Act (EOA) — driving growth in targeted industries.
Potential investment in the manufacturing sector was highlighted at EDA Board meeting, as three manufacturers of pharmaceutical products were approved for Grow New Jersey (Grow NJ) tax credits to either locate or expand in New Jersey.
Grow NJ is the main job creation and retention program administered under the EOA. Continue reading
NJ Economic Development Authority Headquarters Renamed in Honor of Caren Franzini
Caren Franzini
Trenton, NJ, August 8, 2017 — Emily Bader reports in NJBIZ that Governor Chris Christie yesterday signed legislation — Assembly 4713, Burzichelli, D-3, /Prieto, D-32 — to rename the New Jersey Economic Development Authority headquarters at 36 W. State St. in Trenton to the Caren Franzini Memorial Building.
Franzini, who died last January 25, led the EDA for nearly two decades and has made significant contributions toward improving the Garden State’s business climate, the New Jersey Business & Industry Association said.
Franzini joined the EDA in 1991 as its deputy director, and became head of the agency from 1994 to 2012 before founding her own firm, Franzini Consulting LLC in Lambertville. Continue reading
Commercial Center for Innovative Technologies Adds Genomic Prediction, A Startup Fertility Treatment Company
North Brunswick, NJ, August 3, 2017 — Vince Calio reports in NJBIZ that the Commercial Center for Innovative Technologies has a new addition to its family, as Genomic Prediction, a startup fertility treatment company, has moved into the space — and is growing already.
The company was co-founded by Rutgers University associate professor Nathan Treff, and specializes in testing human embryos for a range of chromosomal abnormalities and genetic disorders before they are implanted in women who are seeking in vitro fertilization to become pregnant.
So far, the company’s long-term focus is on developing polygenic tests to predict the risk of diabetes and other conditions. Continue reading
Choose New Jersey CEO Michele Brown: ‘Access to Lab Space, Funding and Partners Help Biotech Companies Grow in Garden State’
Michele Brown (Photo: NJBIZ/Aaron Houston)
Trenton, NJ, August 1, 2017 — Choose New Jersey, Inc. led a delegation representing more than 20 New Jersey organizations — including top life sciences companies, universities, trade associations, state officials — as it showcased New Jersey’s assets and resources for biotechnology companies at BIO International 2017, which was June 19-22 in San Diego, California.
Prior to the BIO event, Choose New Jersey President and Chief Executive Officer Michele Brown in June wrote:
When Hurel Corporation outgrew its incubator space at the Commercialization Center for Innovative Technologies (CCIT) in North Brunswick, New Jersey in 2016, it marked an important milestone for the biotechnology company. Continue reading
NJEDA: Ideal Location, Unique State Resources Give Enteris BioPharma Advantage in Global Marketplace
Trenton, NJ, June 25, 2017 — This week’s BIO International Convention gave leaders from New Jersey’s vast life sciences ecosystem the chance to show emerging companies the advantages of establishing themselves within the State, such as its ideal location on the Eastern seaboard and the large number of pharmaceutical giants that currently call the State “home.”
“The Garden State is truly the best place to start a biopharmaceutical company,” New Jersey Economic Development Authority (EDA) Chief Executive Officer (CEO) Melissa Orsen said. Continue reading
Ex-Roche Campus Reinvented as ‘On3’ Science Center; Developer Seeks to Create Mini-Metropolis in the Suburbs’ for Life Sciences
Nutley, NJ, June 23, 2017 — Owen Proctor reports in The Record/NorthJersey.com that the former Hoffmann-La Roche campus that borders Clifton and Nutley has a new name.
“On3” seeks to incorporate living, working and playing in the Route 3 site, according to Prism Capital Partners’ principal Eugene Diaz. He described the redevelopment as “a mini-metropolis in the suburbs.”
The firm wants to reinvent the 116-acre campus that the pharmaceutical giant began vacating in 2012, creating a synergy among like-minded businesses geared toward life sciences. Continue reading
NJEDA Urges Emerging Tech and Life Sciences Companies to Apply for Funding
Trenton, DC, June 15, 2017 — Brandon Scalea reports in The Star-Ledger that an application administered by the New Jersey Economic Development Authority (EDA) is available for early-stage companies to gain access to capital.
The New Jersey Technology Business Tax Certificate Transfer (NOL) Program is targeted to up-and-coming technology and life science companies in the state. The online application is due June 30.
Kathleen Coviello, EDA director of technology and life sciences, said all eligible companies should take advantage of this opportunity. Continue reading
NJ EDA to Fill Market Need for Seed-Stage Capital Through NJ CoVest Fund; Aims to Help New Innovative Tech and Life Science Companies Thrive
Trenton, NJ, April 18, 2017 — The New Jersey Economic Development Authority (EDA) on April 13 announced the creation of the NJ CoVest Fund, which will provide growth capital to early-stage technology and life sciences companies, driving up to $9 million in investment.
The NJ CoVest Fund will fill a market need in New Jersey, ensuring the availability of capital at a company’s critical stage between product development and commercial operation expansion, where limited funds are currently available and a funding gap exists. Continue reading
Gov. Christie’s Chief Counsel Thomas Scrivo Stepping Down to Chair NJ Economic Development Authority and Return to Private Practice
Thomas Scrivo
Trenton, NJ, March 13, 2017 — Thomas P. Scrivo, Governor Chris Christie’s Chief Counsel, will leave the Administration following a year and a half of service, but the Governor has appointed Scrivo to serve as the new Chairman of the New Jersey Economic Development Authority (NJEDA).
In addition, Mr. Scrivo will return to private practice and form the law firm of O’Toole Scrivo with Senator Kevin O’Toole.
Succeeding Scrivo as Chief Counsel to the Governor will be Gregory Acquaviva, Vice President of State Government Affairs at UnitedHealth Group and former Chief of Staff to Lt. Governor Kim Guadagno. Continue reading
